FdaApplication
ANDA 209522
Identifiers
- fda_app_no: ANDA209522
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 2019-04-19 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED;NASAL |
1 product